Deliberations on Director and Officer Evaluations and Compensation by the Nomination and Compensation Advisory Committee
First written in FY2020. 4 of 10 entries say "Advanced", first in FY2021. Latest entry: 2026-06-22.
- 2026-06-22RestatedGovernance
「Nomination and Compensation Advisory Committee」
The company reconfirms the framework for evaluating officers and deliberating compensation, with the Nomination and Compensation Advisory Committee serving as an advisory body to the Board of Directors. - FY2026The number of meetings of the Nomination and Remuneration Advisory Committee decreased from 3 to 2 per year.Annual report
「During the fiscal year under review, we held 2 meetings of the Nomination and Remuneration Advisory Committee. The attendance of each member of the Nomination and Remuneration Advisory Committee was as follows.」
Continuing the committee that deliberates on the nomination and remuneration of directors and other officers, although the number of meetings decreased from 3 to 2 year on year. - 2026-05-27RestatedGeneral Meetings of Shareholders
「During the current fiscal year, the company held 3 meetings of the Nomination and Compensation Advisory Committee.」
The company reconfirms that the Nomination and Compensation Advisory Committee met 3 times during the year to deliberate executive compensation and related matters. - FY2026-H1RestatedAnnual report
「Based on a resolution at the 153rd Annual General Meeting of Shareholders held on 16 June 2023, we introduced a performance-linked stock-based remuneration plan, the Stock Benefit Trust (BBT-RS (= Board Benefit Trust-Restricted Stock)) (the “Plan”), for the Company’s directors, excluding directors who are Audit and Supervisory Committee members and outside directors among the other directors, and executive officers (collectively, the “Directors and Other Officers”).」
Continuing the performance-linked stock-based remuneration plan introduced in 2023. The shares remaining in the trust totaled 135,843 shares, with a carrying amount of ¥82,049 thousand. - FY2025AdvancedAnnual report
「During the fiscal year under review, we held 3 meetings of the Nomination and Remuneration Advisory Committee. The attendance of each member of the Nomination and Remuneration Advisory Committee was as follows.」
The number of meetings of the Nomination and Remuneration Advisory Committee increased from 2 to 3 year on year, and the committee deliberated on the nomination and remuneration of directors and other officers. - FY2024RestatedAnnual report
「The Nomination and Remuneration Advisory Committee, as an advisory body to the Board of Directors, deliberates on the establishment and revision of executive remuneration and evaluation systems, evaluation results, and the appropriateness of fixed and performance-linked remuneration. During the fiscal year under review, we held 2 meetings of the Nomination and Remuneration Advisory Committee.」
Continuing deliberations by the Nomination and Remuneration Advisory Committee on executive remuneration and evaluation systems, with 2 meetings held during the year. - FY2024-Q2AdvancedAnnual report
「Based on a resolution at the 153rd Annual General Meeting of Shareholders held on 16 June 2023, we introduced a performance-linked stock-based remuneration plan, the Stock Benefit Trust (BBT-RS (= Board Benefit Trust-Restricted Stock)) (the “Plan”), for the Company’s directors, excluding directors who are Audit and Supervisory Committee members and outside directors among the other directors, and executive officers (collectively, the “Directors and Other Officers”).」
The introduction of stock-based remuneration, which was described in the previous fiscal year as a matter for deliberation and recommendation, moved into the implementation phase as a performance-linked stock-based remuneration plan based on a resolution at the Annual General Meeting of Shareholders. The mechanisms for providing shares through a trust and entering into restricted stock transfer agreements have also been specified. - FY2023AdvancedAnnual report
「During the fiscal year under review, we held 2 meetings of the Nomination and Remuneration Advisory Committee and deliberated on the nomination and remuneration of directors.」
Held 2 meetings of the Nomination and Remuneration Advisory Committee and deliberated and submitted recommendations on the appointment of directors, the executive officer system, remuneration limits and the introduction of stock-based remuneration. - FY2021AdvancedAnnual report
「The Nomination and Remuneration Advisory Committee, as an advisory body to the Board of Directors, deliberates on the establishment and revision of executive remuneration and evaluation systems, evaluation results, and the appropriateness of fixed and performance-linked remuneration. It generally meets approximately 2 times per year.」
Clarified that the Nomination and Remuneration Advisory Committee deliberates on executive remuneration and evaluation systems and the appropriateness of fixed and performance-linked remuneration, and generally meets approximately 2 times per year. - FY2020First statedAnnual report
「In addition, to further strengthen the effectiveness of the Board of Directors and the involvement and advice provided by the 2 outside directors who are also Audit and Supervisory Committee members, we established the Nomination and Remuneration Advisory Committee as a forum for constructive dialogue and discussion with the Representative Director, and hold meetings approximately 1 to 2 times per year.」
For the first time, describes a framework in which the Nomination and Remuneration Advisory Committee considers the involvement and advice of outside directors, discusses matters with the Representative Director, and deliberates on executive remuneration and evaluation systems.